Slah Ouerhani

757 total citations
49 papers, 554 citations indexed

About

Slah Ouerhani is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Slah Ouerhani has authored 49 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 18 papers in Surgery and 9 papers in Cancer Research. Recurrent topics in Slah Ouerhani's work include Bladder and Urothelial Cancer Treatments (18 papers), Epigenetics and DNA Methylation (15 papers) and Glutathione Transferases and Polymorphisms (10 papers). Slah Ouerhani is often cited by papers focused on Bladder and Urothelial Cancer Treatments (18 papers), Epigenetics and DNA Methylation (15 papers) and Glutathione Transferases and Polymorphisms (10 papers). Slah Ouerhani collaborates with scholars based in Tunisia, France and Spain. Slah Ouerhani's co-authors include Raja Marrakchi, Amel Ben Ammar Elgaaïed, Mohamed Chébil, Mohamed Riadh Ben Slama, Karim Bougatef, Mohamed Sfaxi, Salem Abbès, M Ayed, Amel Benammar Elgaaïed and M. Chérif and has published in prestigious journals such as Molecular Cancer Therapeutics, BMC Cancer and Inflammation Research.

In The Last Decade

Slah Ouerhani

48 papers receiving 542 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Slah Ouerhani Tunisia 15 335 153 120 100 79 49 554
Yu Qin China 12 380 1.1× 196 1.3× 172 1.4× 136 1.4× 108 1.4× 30 678
Qingyi Wei United States 11 383 1.1× 91 0.6× 149 1.2× 132 1.3× 107 1.4× 29 548
Krzysztof Szyłło Poland 15 282 0.8× 83 0.5× 226 1.9× 141 1.4× 21 0.3× 59 1.1k
L Kasinetz Israel 7 411 1.2× 67 0.4× 65 0.5× 62 0.6× 116 1.5× 9 524
Paweł Mach Germany 16 127 0.4× 53 0.3× 168 1.4× 186 1.9× 36 0.5× 59 646
Emile Youssef United States 13 495 1.5× 80 0.5× 126 1.1× 188 1.9× 13 0.2× 18 713
Matthew P. Borst United States 8 149 0.4× 36 0.2× 65 0.5× 116 1.2× 72 0.9× 11 399
Daniel Torres‐Moreno Spain 12 114 0.3× 41 0.3× 58 0.5× 112 1.1× 64 0.8× 24 399
Daniel Powers United States 9 136 0.4× 58 0.4× 59 0.5× 52 0.5× 161 2.0× 22 570
Mariko Sakata Japan 14 141 0.4× 88 0.6× 81 0.7× 71 0.7× 11 0.1× 29 814

Countries citing papers authored by Slah Ouerhani

Since Specialization
Citations

This map shows the geographic impact of Slah Ouerhani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Slah Ouerhani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Slah Ouerhani more than expected).

Fields of papers citing papers by Slah Ouerhani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Slah Ouerhani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Slah Ouerhani. The network helps show where Slah Ouerhani may publish in the future.

Co-authorship network of co-authors of Slah Ouerhani

This figure shows the co-authorship network connecting the top 25 collaborators of Slah Ouerhani. A scholar is included among the top collaborators of Slah Ouerhani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Slah Ouerhani. Slah Ouerhani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boussetta, Sami, et al.. (2021). Association of a common genetic variant (insertion/deletion) in ACE gene with prostate cancer susceptibility in a Tunisian population. Journal of Clinical Laboratory Analysis. 36(1). e24129–e24129. 7 indexed citations
2.
Boussetta, Sami, Geoffroy Durand, Catherine Voegele, et al.. (2021). Development of a custom next-generation sequencing panel for the determination of bladder cancer risk in a Tunisian cohort. Molecular Biology Reports. 49(2). 1233–1258. 3 indexed citations
3.
Gurtner, Aymone, Nesrine Trabelsi, Isabella Manni, et al.. (2021). The diagnostic applicability of A-type Lamin in non-muscle invasive bladder cancer. Annals of Diagnostic Pathology. 54. 151808–151808. 4 indexed citations
4.
Gurtner, Aymone, Nesrine Trabelsi, Isabella Manni, et al.. (2020). Uncovering the expression patterns and the clinical significance of miR-182, miR-205, miR-27a and miR-369 in patients with urinary bladder cancer. Molecular Biology Reports. 47(11). 8819–8830. 4 indexed citations
5.
Cicchillitti, Lucia, Aymone Gurtner, H. Ayed, et al.. (2019). The clinical and prognostic value of miR-9 gene expression in Tunisian patients with bladder cancer. Molecular Biology Reports. 46(5). 4743–4750. 3 indexed citations
6.
Spagnuolo, Manuela, Nesrine Trabelsi, Aymone Gurtner, et al.. (2019). miR-143 expression profiles in urinary bladder cancer: correlation with clinical and epidemiological parameters. Molecular Biology Reports. 47(2). 1283–1292. 9 indexed citations
7.
Bougatef, Karim, et al.. (2018). Polymorphisms in XPC gene and risk for prostate cancer. Molecular Biology Reports. 46(1). 1117–1125. 6 indexed citations
8.
9.
Ouerhani, Slah, et al.. (2013). The prevalence and prognostic significance of KRAS mutation in bladder cancer, chronic myeloid leukemia and colorectal cancer. Molecular Biology Reports. 40(6). 4109–4114. 29 indexed citations
10.
Ouerhani, Slah, et al.. (2012). KIT mutation detection in Tunisian patients with newly diagnosed myelogenous leukemia: prevalence and prognostic significance. Cancer Genetics. 205(9). 436–441. 3 indexed citations
11.
Ouerhani, Slah, Bechr Hamrita, Karim Bougatef, et al.. (2011). Smoking and Polymorphisms in Xenobiotic Metabolism and DNA Repair Genes are Additive Risk Factors Affecting Bladder Cancer in Northern Tunisia. Pathology & Oncology Research. 17(4). 879–886. 37 indexed citations
12.
Bougatef, Karim, Raja Marrakchi, Nejla Stambouli, et al.. (2011). The effect of tobacco, XPC, ERCC2 and ERCC5 genetic variants in bladder cancer development. BMC Cancer. 11(1). 101–101. 37 indexed citations
13.
Stambouli, Nejla, et al.. (2010). The impact of smoking and polymorphic enzymes of xenobiotic metabolism on the stage of bladder tumors: a generalized ordered logistic regression analysis. Journal of Cancer Research and Clinical Oncology. 136(7). 1111–1116. 5 indexed citations
14.
Fekih‐Mrissa, Najiba, et al.. (2010). HLA class II alleles and multiple sclerosis in Tunisian patients. Clinical Neurology and Neurosurgery. 112(10). 849–852. 14 indexed citations
15.
Marrakchi, Raja, Slah Ouerhani, Karim Bougatef, et al.. (2009). Interleukin 10 promoter region polymorphisms in inflammatory bowel disease in Tunisian population. Inflammation Research. 58(3). 155–160. 11 indexed citations
16.
Ouerhani, Slah, et al.. (2009). Do smoking and polymorphisms in xenobiotic metabolizing enzymes affect the histological stage and grade of bladder tumors?. Bulletin du Cancer. 96(5). e23–e29. 4 indexed citations
17.
Marrakchi, Raja, Karim Bougatef, Slah Ouerhani, et al.. (2009). 3020insC insertion in NOD2/CARD15 gene, a prevalent variant associated with anti-Saccharomyces cerevisiae antibodies and ileal location of Crohn’s disease in Tunisian population. Inflammation Research. 58(4). 218–223. 14 indexed citations
18.
Bougatef, Karim, Slah Ouerhani, Nadia Kourda, et al.. (2008). Prevalence of mutations in APC, CTNNB1, and BRAF in Tunisian patients with sporadic colorectal cancer. Cancer Genetics and Cytogenetics. 187(1). 12–18. 18 indexed citations
19.
Bougatef, Karim, Raja Marrakchi, Slah Ouerhani, et al.. (2008). No evidence of the APC D1822V missense variant's pathogenicity in Tunisian patients with sporadic colorectal cancer. Pathologie Biologie. 57(3). e67–e71. 7 indexed citations
20.
Ouerhani, Slah, et al.. (2006). The role of glutathione transferases M1 and T1 in individual susceptibility to bladder cancer in a Tunisian population. Annals of Human Biology. 33(5-6). 529–535. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yu Qin Breakdown of academic impact, for papers by Qingyi Wei Breakdown of academic impact, for papers by Krzysztof Szyłło Breakdown of academic impact, for papers by L Kasinetz Breakdown of academic impact, for papers by Paweł Mach Breakdown of academic impact, for papers by Emile Youssef Breakdown of academic impact, for papers by Matthew P. Borst Breakdown of academic impact, for papers by Daniel Torres‐Moreno Breakdown of academic impact, for papers by Daniel Powers Breakdown of academic impact, for papers by Mariko Sakata
Rankless by CCL
2026